β-Catenin is markedly induced in a murine model of an arteriovenous fistula: The effect of metalloproteinase inhibition

American Journal of Physiology - Renal Physiology

Volumn 299, Issue 6, 2010, Pages

  Nath, Karl A ^a,b   Grande, Joseph P ^a   Kang, Lu ^a   Juncos, Julio P ^a   Ackerman, Allan W ^a   Croatt, Anthony J ^a   Katusic, Zvonimir S ^a  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Glycogen synthase kinase 3 ; Matrix metalloproteinase 9; Neointimal hyperplasia

Indexed keywords

BETA CATENIN; CYCLINE; GELATINASE B; GLYCOGEN SYNTHASE KINASE 3BETA; INTEGRIN LINKED KINASE; MATRIX METALLOPROTEINASE; MYC PROTEIN; NERVE CELL ADHESION MOLECULE; CADHERIN; CDH2 PROTEIN, MOUSE; DOXYCYCLINE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; INTEGRIN-LINKED KINASE; MYC PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS FISTULA; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; HEMODIALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; VASCULAR ACCESS; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING; ANIMAL; ARTERIOVENOUS SHUNT; BIOSYNTHESIS; C57BL MOUSE; CAROTID ARTERY; DRUG ANTAGONISM; HYPERPLASIA; JUGULAR VEIN; NEOINTIMA; PATHOLOGY; UPREGULATION;

ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; BETA CATENIN; CADHERINS; CAROTID ARTERIES; DOXYCYCLINE; GLYCOGEN SYNTHASE KINASE 3; HYPERPLASIA; JUGULAR VEINS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; NEOINTIMA; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; UP-REGULATION;

EID: 78649943176     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00488.2010     Document Type: Article

References (43)

1. Agarwal A, Segal MS. Intimal exuberance: veins in jeopardy. Am J Pathol 162: 1759-1761, 2003.
2. Allon M. Current management of vascular access. Clin J Am Soc Nephrol 2: 786-800, 2007.
3. Bedel A, Negre-Salvayre A, Heeneman S, Grazide MH, Thiers JC, Salvayre R, Maupas-Schwalm F. E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein. Circ Res 103: 694-701, 2008.
4. Bendeck MP, Conte M, Zhang M, Nili N, Strauss BH, Farwell SM. Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. Am J Pathol 160: 1089-1095, 2002.
5. Bowley E, O'Gorman DB, Gan BS. Beta-catenin signaling in fibroproliferative disease. J Surg Res 138: 141-150, 2007.
6. Cadigan KM. Wnt-beta-catenin signaling. Curr Biol 18: R943-R947, 2008.
7. Chan CY, Chen YS, Ma MC, Chen CF. Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats. J Vasc Surg 45: 804-811, 2007.
8. Chang CJ, Ko YS, Ko PJ, Hsu LA, Chen CF, Yang CW, Hsu TS, Pang JH. Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int 68: 1312-1319, 2005.
9. Cho A, Reidy MA. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 91: 845-851, 2002.
10. Chung AW, Yang HH, Radomski MW, van Breemen C. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 102: e73-e85, 2008.
11. Couffinhal T, Dufourcq P, Duplaa C. Beta-catenin nuclear activation: common pathway between Wnt and growth factor signaling in vascular smooth muscle cell proliferation? Circ Res 99: 1287-1289, 2006. (Pubitemid 44949663)
12. Croatt AJ, Grande JP, Hernandez MC, Ackerman AW, Katusic ZS, Nath KA. Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAME. Am J Pathol 176: 2530-2541, 2010.
13. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, Liu Y. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008, 2009.
14. Diskin C, Stokes TJ, Dansby LM, Radcliff L, Carter TB. Doxycycline may reduce the incidence of aneurysms in haemodialysis vascular accesses. Nephrol Dial Transplant 20: 959-961, 2005. (Pubitemid 40704033)
15. Doble BW, Woodgett JR. Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions. Cells Tissues Organs 185: 73-84, 2007.
16. Dwivedi A, Sala-Newby GB, George SJ. Regulation of cell-matrix contacts and beta-catenin signaling in VSMC by integrin-linked kinase: implications for intimal thickening. Basic Res Cardiol 103: 244-256, 2008.
17. Dwivedi A, Slater SC, George SJ. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation. Cardiovasc Res 81: 178-186, 2009.
18. Friedrich EB, Clever YP, Wassmann S, Werner N, Bohm M, Nickenig G. Role of integrin-linked kinase in vascular smooth muscle cells: regulation by statins and angiotensin II. Biochem Biophys Res Commun 349: 883-889, 2006.
19. Gosens R, Meurs H, Schmidt M. The GSK-3/beta-catenin-signalling axis in smooth muscle and its relationship with remodelling. Naunyn Schmiedebergs Arch Pharmacol 378: 185-191, 2008.
20. Hakim R, Himmelfarb J. Hemodialysis access failure: a call to action. Kidney Int 54: 1029-1040, 1998.
21. He W, Dai C, Li Y, Zeng G, Monga SP, Liu Y. Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20: 765-776, 2009.
22. Ho B, Hou G, Pickering JG, Hannigan G, Langille BL, Bendeck MP. Integrin-linked kinase in the vascular smooth muscle cell response to injury. Am J Pathol 173: 278-288, 2008.
23. Juncos JP, Tracz MJ, Croatt AJ, Grande JP, Ackerman AW, Katusic ZS, Nath KA. Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse. Kidney Int 74: 47-51, 2008.
24. Kanwar YS. Functional duality of progenitor cells influxing into arteriovenous fistula during its neoangiogenesis. Am J Physiol Renal Physiol 293: F468-F469, 2007.
25. Li Y, Tan X, Dai C, Stolz DB, Wang D, Liu Y. Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol 20: 1907-1918, 2009.
26. Lin CC, Yang WC, Chung MY, Lee PC. Functional polymorphisms in matrix metalloproteinases-1, -3, -9 are associated with arteriovenous fistula patency in hemodialysis patients. Clin J Am Soc Nephrol 5: 1805-1814, 2010.
27. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21: 212-222, 2010.
28. Loftus IM, Porter K, Peterson M, Boyle J, London NJ, Bell PR, Thompson MM. MMP inhibition reduces intimal hyperplasia in a human vein graft stenosis model. Ann NY Acad Sci 878: 547-550, 1999.
29. Masckauchan TN, Kitajewski J. Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight. Physiology (Bethesda) 21: 181-188, 2006.
30. Murali NS, Ackerman AW, Croatt AJ, Cheng J, Grande JP, Sutor SL, Bram RJ, Bren GD, Badley AD, Alam J, Nath KA. Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. Am J Physiol Renal Physiol 292: F837-F844, 2007.
31. Oloumi A, Syam S, Dedhar S. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells. Oncogene 25: 7747-7757, 2006. (Pubitemid 44967969)
32. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 54: 24-38, 2008. (Pubitemid 351182593)
33. Quasnichka H, Slater SC, Beeching CA, Boehm M, Sala-Newby GB, George SJ. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression. Circ Res 99: 1329-1337, 2006.
34. Roy-Chaudhury P, Spergel LM, Besarab A, Asif A, Ravani P. Biology of arteriovenous fistula failure. J Nephrol 20: 150-163, 2007.
35. Schwab SJ, Harrington JT, Singh A, Roher R, Shohaib SA, Perrone RD, Meyer K, Beasley D. Vascular access for hemodialysis. Kidney Int 55: 2078-2090, 1999.
36. Tracz MJ, Juncos JP, Croatt AJ, Ackerman AW, Grande JP, Knutson KL, Kane GC, Terzic A, Griffin MD, Nath KA. Deficiency of heme oxygenase-1 impairs renal hemodynamics and exaggerates systemic inflammatory responses to renal ischemia. Kidney Int 72: 1073-1080, 2007.
37. Uglow EB, Slater S, Sala-Newby GB, Aguilera-Garcia CM, Angelini GD, Newby AC, George SJ. Dismantling of cadherin-mediated cell-cell contacts modulates smooth muscle cell proliferation. Circ Res 92: 1314-1321, 2003.
38. van de Schans VA, Smits JF, Blankesteijn WM. The Wnt/frizzled pathway in cardiovascular development and disease: friend or foe? Eur J Pharmacol 585: 338-345, 2008.
39. Wang X, Xiao Y, Mou Y, Zhao Y, Blankesteijn WM, Hall JL. A role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling. Circ Res 90: 340-347, 2002.
40. Wu D, Pan W. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci 35: 161-168, 2010.
41. Xiong W, Knispel RA, Dietz HC, Ramirez F, Baxter BT. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome. J Vasc Surg 47: 166-172, 2008.
42. Zeng X, Huang H, Tamai K, Zhang X, Harada Y, Yokota C, Almeida K, Wang J, Doble B, Woodgett J, Wynshaw-Boris A, Hsieh JC, He X. Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. Development 135: 367-375, 2008. (Pubitemid 351228428)
43. Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R, Okamura H, Woodgett J, He X. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438: 873-877, 2005. (Pubitemid 41753071)